3
Announcements
Trials
Browse
Landscape
Status
Completed
15
Terminated
2
Unknown
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
CNS
26
Sarcoma
9
Lymphoid
2
Genitourinary
2
Thoracic
1
Other hematologic neoplasm
1
Other
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
Breast
1
Conditions
Ovarian Neoplasms
401
Uterine Cervical Neoplasms
399
Endometrial Neoplasms
195
Carcinoma, Ovarian Epithelial
99
Breast Neoplasms
71
Fallopian Tube Neoplasms
70
Uterine Cervical Dysplasia
67
Neoplasms
51
Colorectal Neoplasms
40
Pancreatic Neoplasms
38
Stomach Neoplasms
37
Recurrence
31
Papillomavirus Infections
31
Peritoneal Neoplasms
30
Uterine Neoplasms
29
Vulvar Neoplasms
27
Prostatic Neoplasms
25
Lung Neoplasms
23
Urinary Bladder Neoplasms
21
Esophageal Neoplasms
21
Melanoma
20
Colonic Neoplasms
20
Head and Neck Neoplasms
19
Gynecologic Cancer
19
Neoplasm Metastasis
17
Endometrial Hyperplasia
17
Carcinoma, Non-Small-Cell Lung
17
Squamous Intraepithelial Lesions
16
Sarcoma
16
Ovarian Cysts
15
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Oligodendroglioma
×
Gynecologic
×
Clear all
NCT03896958
2020-12-04
PIONEER
SpeciCare
Unknown
1,000 enrolled